SpectraA Technology IPO

SME

SpectraA Technology Solutions provides end-to-end turnkey engineering solutions, design, and fabrication of processing equipment for breweries, beverages, and pharmaceuticals.

Verdict: Neutral

Est. GMP

₹0 (0%)

Price range

₹118

Lot size

2400

Issue size

₹42.52 Cr

Allotment

22 Sept

Listing

24 Sept

Issue progress

Subscription & allotment tracker

Updates automatically

Upcoming
Bidding opens
17 Sept
Upcoming
Bidding closes
21 Sept
Upcoming
Allotment
22 Sept
Upcoming
Listing
24 Sept

Latest subscription

Subscription figures will appear once the exchange publishes bidding data.

Review

1. Grey market premium

★★★★★

GMP is currently flat at 0%, showing subdued listing excitement.

2. Company financials

★★★★★

The company has demonstrated consistent revenue and margin growth driven by demand in liquid processing industries.

3. Subscription status

★★★★★

Issue is yet to open for bidding; retail and HNI appetite will dictate momentum.

4. Anchor investors

★★★★★

Anchor portion allocation details are pending final disclosure for this SME issue.

Company financials

Amount ₹ in Crores

Period	Revenue	Expense	EBITDA	PAT	Assets
2024	₹89.68	₹86.85	₹8.42	₹2.00	₹66.64
2025	₹75.53	₹68.03	—	₹4.91	₹100.00
2026	₹103.05	₹87.57	—	₹11.56	₹106.29

Issue allocation & lock-in

Bidding date

August 16, 2026

Subscription

Not open for bidding yet.

Anchor investors

Anchor investor names will appear once the exchange publishes the allocation letter.

Anchor allotment details not finalized or publicly available yet.

Risks

ConcentrationHeavily reliant on capex cycles within the brewery and alcoholic beverage sectors.
FinancialLong working capital cycles and inventory holding periods typical of EPC and plant fabrication.
OtherProject execution delays or raw material cost spikes can significantly erode fixed-price contract margins.

Compiled automatically from official and unofficial public sources · review updated 11/9/2026, 9:10:18 am. GMP is an unofficial estimate and AI is used to gather and summarise this data — verify before investing. Not investment advice.